Effect of honey consumption on type 2 diabetes

Effect of honey consumption in comparison with not taking honey on glycemic control and oxidant and antioxidant compounds in patients with type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015052222364N1

Enrollment

Registered

2015-07-26

Start date

2015-04-09

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: The intervention group consume Astragalus honey ( 50 grams per day) three times between meals for 8 weeks. Intervention 2: Control group do not consume honey.

Treatment - Other

The intervention group consume Astragalus honey ( 50 grams per day) three times between meals for 8 weeks.

Control group do not consume honey.

Eligibility

Sex/Gender

All

Age

35 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: type II diabetic patient with a fasting blood sugar less than 200 milligrams per deciliter ; free of a history or presence of malignancy, acute and emergency states, a history of major operations, a drug history of Immunomodulators, cytotoxic or immunosuppressive agents, free of pregnancy or lactation if female; and not using insulin for diabetes control. Exclusion criteria: Participants will exclude in the case of any kind of acute diseases, hospitalization or meet the criteria mentioned in Inclusion criteria.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Fasting blood sugar. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period, 8 weeks after the start of the second period. Method of measurement: Pars Azmun Kit.;Insulin level. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period, 8 weeks after the start of the second period. Method of measurement: Immunoradiometric Assay.;Serum malondialdehyde. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period, 8 weeks after the start of the second period. Method of measurement: Spectrophotometry method.;Serum total antioxidant capacity. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period, 8 weeks after the start of the second period. Method of measurement: Ferric reducing ability of plasma method (FRAP method).	—

Measure

Time frame

Fasting blood sugar. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period, 8 weeks after the start of the second period. Method of measurement: Pars Azmun Kit.;Insulin level. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period, 8 weeks after the start of the second period. Method of measurement: Immunoradiometric Assay.;Serum malondialdehyde. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period, 8 weeks after the start of the second period. Method of measurement: Spectrophotometry method.;Serum total antioxidant capacity. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period, 8 weeks after the start of the second period. Method of measurement: Ferric reducing ability of plasma method (FRAP method).

—

Secondary

Measure	Time frame
Blood pressure. Timepoint: Baseline, 4 weeks after baseline, 8 weeks after baseline, the end of the washout period, 4 weeks after the start of the second period of study , 8 weeks after the start of the second period of study. Method of measurement: mercury manometer.;Weight. Timepoint: Baseline, 4 weeks after baseline, 8 weeks after baseline, the end of the washout period, 4 weeks after the start of the second period of study , 8 weeks after the start of the second period of stud. Method of measurement: digital scale.;Waist circumference. Timepoint: Baseline, 4 weeks after baseline, 8 weeks after baseline, the end of the washout period, 4 weeks after the start of the second period of study , 8 weeks after the start of the second period of study. Method of measurement: meter.;Hip circumference. Timepoint: Baseline, 4 weeks after baseline, 8 weeks after baseline, the end of the washout period, 4 weeks after the start of the second period of study , 8 weeks after the start of the second period of study. Method of measurement: meter.	—

Measure

Time frame

Blood pressure. Timepoint: Baseline, 4 weeks after baseline, 8 weeks after baseline, the end of the washout period, 4 weeks after the start of the second period of study , 8 weeks after the start of the second period of study. Method of measurement: mercury manometer.;Weight. Timepoint: Baseline, 4 weeks after baseline, 8 weeks after baseline, the end of the washout period, 4 weeks after the start of the second period of study , 8 weeks after the start of the second period of stud. Method of measurement: digital scale.;Waist circumference. Timepoint: Baseline, 4 weeks after baseline, 8 weeks after baseline, the end of the washout period, 4 weeks after the start of the second period of study , 8 weeks after the start of the second period of study. Method of measurement: meter.;Hip circumference. Timepoint: Baseline, 4 weeks after baseline, 8 weeks after baseline, the end of the washout period, 4 weeks after the start of the second period of study , 8 weeks after the start of the second period of study. Method of measurement: meter.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Masoume Akhlaghi

Shiraz University of Medical Science

msm.akhlaghi@gmail.com+98 71 3725 1001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026